wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33903949-795A12EE-D14A-42B3-9090-23413B166093
Q33903949-795A12EE-D14A-42B3-9090-23413B166093
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33903949-795A12EE-D14A-42B3-9090-23413B166093
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling
P2860
Q33903949-795A12EE-D14A-42B3-9090-23413B166093
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33903949-795A12EE-D14A-42B3-9090-23413B166093
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df29a6717dc2a60c773ac1c1a6b27327b08cfa68
P2860
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.